Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. pediatric research 
3. infections and immunity 
4. article
•  Infections and Immunity
•  Published: May 2009
Host/Pathogen Interactions


Molecular Pathogenesis of
Staphylococcus aureus Infection
•  George Y Liu
1,2 na1 
Pediatric Research volume 65, pages 71–77 (2009)Cite this article
•  29k Accesses
•  176 Citations
•  2 Altmetric
•  Metrics details
Abstract
S. aureus has evolved a comprehensive strategy to address the
challenges posed by the human immune system. The emergence of
community-associated methicillin-resistant S. aureus (CA-MRSA)
infections in individuals with no predisposing conditions suggests
an increased pathogenicity of the bacterium, which may be related
to acquisition of novel genetic elements. Remarkably, despite an
abundance of research, the underlying cause of the epidemic is not
known. Here, the various strategies used by S. aureus to evade
obstacles laid out by the human host during colonization and
infection were reviewed. The controversies surrounding MRSA
research were described, and how acquisition of the novel genes
could explain the increased incidence and severity of CA-MRSA
diseases was described.
Log in or create a free account to read this
content
Gain free access to this article, as well as selected content from this
journal and more on nature.com


 Access through your institution
or
 Sign in or create an account 
[image] Continue with Google 
[image] Continue with ORCiD 
Abbreviations
agr,:
accessory gene regulator
ACME:
arginine catabolic mobile element
CA-MRSA:
community-associated methicillin-resistant S. aureus
HA-MRSA:
healthcare-associated methicillin-resistant S. aureus
MSSA:
methicillin-sensitive S. aureus
PSM:
phenol soluble modulin
PVL:
Panton-Valentine Leukocidin
ROS:


reactive oxygen species
SCCmec:
Staphylococcal cassette chromosome mec
References
1. Diep BA, Otto M 2008 The role of virulence determinants in
community-associated MRSA pathogenesis. Trends Microbiol
16: 361–369
Article  CAS  Google Scholar 
2. Gordon RJ, Lowy FD 2008 Pathogenesis of methicillin-
resistant Staphylococcus aureus infection. Clin Infect Dis 46:
S350–S359
Article  CAS  Google Scholar 
3. Foster TJ 2005 Immune evasion by staphylococci. Nat Rev
Microbiol 3: 948–958
Article  CAS  Google Scholar 
4. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van
Belkum A, Verbrugh HA, Nouwen JL 2005 The role of nasal
carriage in Staphylococcus aureus infections. Lancet Infect Dis
5: 751–762
Article  Google Scholar 
5. van Belkum A, Emonts M, Wertheim H, de Jongh C, Nouwen
J, Bartels H, Cole A, Hermans P, Boelens H, Toom NL,
Snijders S, Verbrugh H, van Leeuwen W 2007 The role of
human innate immune factors in nasal colonization by
Staphylococcus aureus. Microbes Infect 9: 1471–1477
Article  CAS  Google Scholar 
6. Rooijakkers SH, van Kessel KP, van Strijp JA 2005


Staphylococcal innate immune evasion. Trends Microbiol 13:
596–601
Article  CAS  Google Scholar 
7. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A,
Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM,
Meester MH, Verbrugh HA 2004 Risk and outcome of
nosocomial Staphylococcus aureus bacteraemia in nasal
carriers versus non-carriers. Lancet 364: 703–705
Article  Google Scholar 
8. von Eiff C, Becker K, Machka K, Stammer H, Peters G 2001
Nasal carriage as a source of Staphylococcus aureus
bacteremia. Study Group. N Engl J Med 344: 11–16
Article  CAS  Google Scholar 
9. Wertheim HF, van Kleef M, Vos MC, Ott A, Verbrugh HA,
Fokkens W 2006 Nose picking and nasal carriage of
Staphylococcus aureus. Infect Control Hosp Epidemiol 27: 863–
867
Article  Google Scholar 
10. Ritz HL, Kirkland JJ, Bond GG, Warner EK, Petty GP 1984
Association of high levels of serum antibody to staphylococcal
toxic shock antigen with nasal carriage of toxic shock
antigen-producing strains of Staphylococcus aureus. Infect
Immun 43: 954–958
CAS  PubMed  PubMed Central  Google Scholar 
11. Wertheim HF, Walsh E, Choudhurry R, Melles DC, Boelens
HA, Miajlovic H, Verbrugh HA, Foster T, van Belkum 2008 A
key role for clumping factor B in Staphylococcus aureus nasal
colonization of humans. PLoS Med 5: e17
Article  Google Scholar 
12. Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturiya T,


Kalbacher H, Gross M, Nicholson G, Neumeister B, Mond JJ,
Peschel A 2004 Role of teichoic acids in Staphylococcus aureus
nasal colonization, a major risk factor in nosocomial
infections. Nat Med 10: 243–245
Article  CAS  Google Scholar 
13. Gonzalez-Zorn B, Senna JP, Fiette L, Shorte S, Testard A,
Chignard M, Courvalin P, Grillot-Courvalin C 2005 Bacterial
and host factors implicated in nasal carriage of methicillin-
resistant Staphylococcus aureus in mice. Infect Immun 73:
1847–1851
Article  CAS  Google Scholar 
14. Lina G, Boutite F, Tristan A, Bes M, Etienne J, Vandenesch F
2003 Bacterial competition for human nasal cavity
colonization: role of Staphylococcal agr alleles. Appl Environ
Microbiol 69: 18–23
Article  CAS  Google Scholar 
15. Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot
R, Rumke HC, Verbrugh HA, Hermans PW 2004 Colonisation
by Streptococcus pneumoniae and Staphylococcus aureus in
healthy children. Lancet 363: 1871–1872
Article  CAS  Google Scholar 
16. Cohen R, Levy C, Thollot F, de La Rocque F, Koskas M,
Bonnet E, Fritzell B, Varon E 2007 Pneumococcal conjugate
vaccine does not influence Staphylococcus aureus carriage in
young children with acute otitis media. Clin Infect Dis 45:
1583–1587
Article  Google Scholar 
17. Regev-Yochay G, Trzcinski K, Thompson CM, Malley R,
Lipsitch M 2006 Interference between Streptococcus
pneumoniae and Staphylococcus aureus: In vitro hydrogen
peroxide-mediated killing by Streptococcus pneumoniae. J
Bacteriol 188: 4996–5001


Article  CAS  Google Scholar 
18. Park B, Nizet V, Liu GY 2008 Role of Staphylococcus aureus
catalase in niche competition against Streptococcus
pneumoniae. J Bacteriol 190: 2275–2278
Article  CAS  Google Scholar 
19. Novick RP 2003 Autoinduction and signal transduction in the
regulation of staphylococcal virulence. Mol Microbiol 48:
1429–1449
Article  CAS  Google Scholar 
20. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda
Y, Krikae F, Kirikae T, Gotz F 2006 Not lipoteichoic acid but
lipoproteins appear to be the dominant immunobiologically
active compounds in Staphylococcus aureus. J Immunol 177:
3162–3169
Article  CAS  Google Scholar 
21. Fournier B, Philpott DJ 2005 Recognition of Staphylococcus
aureus by the innate immune system. Clin Microbiol Rev 18:
521–540
Article  CAS  Google Scholar 
22. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD,
Horton MR 2006 Hyaluronan fragments act as an endogenous
danger signal by engaging TLR2. J Immunol 177: 1272–1281
Article  CAS  Google Scholar 
23. Pisetsky DS 2007 The role of nuclear macromolecules in
innate immunity. Proc Am Thorac Soc 4: 258–262
Article  CAS  Google Scholar 
24. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM,
Lukacs NW, Hogaboam CM, Kunkel SL 2008 TLR3 is an
endogenous sensor of tissue necrosis during acute


inflammatory events. J Exp Med 205: 2609–2621
Article  CAS  Google Scholar 
25. Kubica M, Guzik K, Koziel J, Zarebski M, Richter W,
Gajkowska B, Golda A, Maciag-Gudowska A, Brix K, Shaw L,
Foster T, Potempa J 2008 A potential new pathway for
Staphylococcus aureus dissemination: the silent survival of S.
aureus phagocytosed by human monocyte-derived
macrophages. PLoS One 3: e1409
Article  Google Scholar 
26. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van
Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van
Strijp JA 2004 Chemotaxis inhibitory protein of
Staphylococcus aureus, a bacterial antiinflammatory agent. J
Exp Med 199: 687–695
Article  CAS  Google Scholar 
27. Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock
JI, Herrmann M, Preissner KT 2002 Staphylococcus aureus
extracellular adherence protein serves as anti-inflammatory
factor by inhibiting the recruitment of host leukocytes. Nat
Med 8: 687–693
Article  CAS  Google Scholar 
28. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson
G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A,
van Kessel KP, van Strijp JA 2001 Staphylococcus aureus
resistance to human defensins and evasion of neutrophil
killing via the novel virulence factor MprF is based on
modification of membrane lipids with l-lysine. J Exp Med
193: 1067–1076
Article  CAS  Google Scholar 
29. Collins LV, Kristian SA, Weidenmaier C, Faigle M, Van Kessel
KP, Van Strijp JA, Gotz F, Neumeister B, Peschel A 2002
Staphylococcus aureus strains lacking d-alanine modifications


of teichoic acids are highly susceptible to human neutrophil
killing and are virulence attenuated in mice. J Infect Dis 186:
214–219
Article  CAS  Google Scholar 
30. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo
M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W,
McAleese F, Foster T, Travis J, Potempa J 2004 Degradation
of human antimicrobial peptide LL-37 by Staphylococcus
aureus-derived proteinases. Antimicrob Agents Chemother 48:
4673–4679
Article  CAS  Google Scholar 
31. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski
A 2004 Staphylococcus aureus resists human defensins by
production of staphylokinase, a novel bacterial evasion
mechanism. J Immunol 172: 1169–1176
Article  CAS  Google Scholar 
32. Tomita T, Kamio Y 1997 Molecular biology of the pore-
forming cytolysins from Staphylococcus aureus, alpha- and
gamma-hemolysins and leukocidin. Biosci Biotechnol Biochem
61: 565–572
Article  CAS  Google Scholar 
33. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li
M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo
FR, Otto M 2007 Identification of novel cytolytic peptides as
key virulence determinants for community-associated MRSA.
Nat Med 13: 1510–1514
Article  CAS  Google Scholar 
34. Maresso AW, Schneewind O 2006 Iron acquisition and
transport in Staphylococcus aureus. Biometals 19: 193–203
Article  CAS  Google Scholar 


35. Drechsel H, Freund S, Nicholson G, Haag H, Jung O, Zahner
H, Jung G 1993 Purification and chemical characterization of
staphyloferrin B, a hydrophilic siderophore from
staphylococci. Biometals 6: 185–192
Article  CAS  Google Scholar 
36. Courcol RJ, Trivier D, Bissinger MC, Martin GR, Brown MR
1997 Siderophore production by Staphylococcus aureus and
identification of iron-regulated proteins. Infect Immun 65:
1944–1948
CAS  PubMed  PubMed Central  Google Scholar 
37. Lee LY, Miyamoto YJ, McIntyre BW, Hook M, McCrea KW,
McDevitt D, Brown EL 2002 The Staphylococcus aureus Map
protein is an immunomodulator that interferes with T cell-
mediated responses. J Clin Invest 110: 1461–1471
Article  CAS  Google Scholar 
38. Llewelyn M, Cohen J 2002 Superantigens: microbial agents
that corrupt immunity. Lancet Infect Dis 2: 156–162
Article  CAS  Google Scholar 
39. Goodyear CS, Silverman GJ 2004 Staphylococcal toxin
induced preferential and prolonged in vivo deletion of innate-
like B lymphocytes. Proc Natl Acad Sci USA 101: 11392–
11397
Article  CAS  Google Scholar 
40. von Eiff C, Peters G, Becker K 2006 The small colony variant
(SCV) concept—the role of staphylococcal SCVs in persistent
infections. Injury 37: S26–S33
Article  Google Scholar 
41. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray
S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS,
Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK


2007 Invasive methicillin-resistant Staphylococcus aureus
infections in the United States. JAMA 298: 1763–1771
Article  CAS  Google Scholar 
42. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan
T, Gaynes R 2006 Changes in the epidemiology of methicillin-
resistant Staphylococcus aureus in intensive care units in US
hospitals, 1992–2003. Clin Infect Dis 42: 389–391
Article  Google Scholar 
43. Eady EA, Cove JH 2003 Staphylococcal resistance revisited:
community-acquired methicillin resistant Staphylococcus
aureus—an emerging problem for the management of skin
and soft tissue infections. Curr Opin Infect Dis 16: 103–124
Article  CAS  Google Scholar 
44. Laurent F, Lelievre H, Cornu M, Vandenesch F, Carret G,
Etienne J, Flandrois JP 2001 Fitness and competitive growth
advantage of new gentamicin-susceptible MRSA clones
spreading in French hospitals. J Antimicrob Chemother 47:
277–283
Article  CAS  Google Scholar 
45. Voyich JM, Braughton KR, Sturdevant DE, Whitney AR, Said-
Salim B, Porcella SF, Long RD, Dorward DW, Gardner DJ,
Kreiswirth BN, Musser JM, DeLeo FR 2005 Insights into
mechanisms used by Staphylococcus aureus to avoid
destruction by human neutrophils. J Immunol 175: 3907–
3919
Article  CAS  Google Scholar 
46. Shopsin B, Drlica-Wagner A, Mathema B, Adhikari RP,
Kreiswirth BN, Novick RP 2008 Prevalence of agr dysfunction
among colonizing Staphylococcus aureus strains. J Infect Dis
198: 1171–1174
Article  Google Scholar 


47. Vuong C, Saenz HL, Gotz F, Otto M 2000 Impact of the agr
quorum-sensing system on adherence to polystyrene in
Staphylococcus aureus. J Infect Dis 182: 1688–1693
Article  CAS  Google Scholar 
48. Liu C, Graber CJ, Karr M, Diep BA, Basuino L, Schwartz BS,
Enright MC, O'Hanlon SJ, Thomas JC, Perdreau-Remington F,
Gordon S, Gunthorpe H, Jacobs R, Jensen P, Leoung G,
Rumack JS, Chambers HF 2008 A population-based study of
the incidence and molecular epidemiology of methicillin-
resistant Staphylococcus aureus disease in San Francisco,
2004–2005. Clin Infect Dis 46: 1637–1646
Article  CAS  Google Scholar 
49. 1999 Four Pediatric Deaths from Community-Acquired
Methicillin-Resistant Staphylococcus aureus—Minnesota and
North Dakota, 1997–1999. MMWR Morb Mortal Wkly Rep 48:
707–710
50. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR,
Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME,
Etienne J 2003 Community-acquired methicillin-resistant
Staphylococcus aureus carrying six genes: worldwide
emergence. Emerg Infect Dis 9: 978–984
Article  Google Scholar 
51. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE,
McDougal LK, Carey RB, Talan DA 2006 Methicillin-resistant
S. aureus infections among patients in the emergency
department. N Engl J Med 355: 666–674
Article  CAS  Google Scholar 
52. Stryjewski ME, Chambers HF 2008 Skin and soft-tissue
infections caused by community-acquired methicillin-resistant
Staphylococcus aureus. Clin Infect Dis 46: S368–S377
Article  CAS  Google Scholar 


53. Bradley SF 2005 Staphylococcus aureus pneumonia: emergence
of MRSA in the community. Semin Respir Crit Care Med 26:
643–649
Article  Google Scholar 
54. Pannaraj PS, Hulten KG, Gonzalez BE, Mason EO Jr, Kaplan
SL 2006 Infective pyomyositis and myositis in children in the
era of community-acquired, methicillin-resistant
Staphylococcus aureus infection. Clin Infect Dis 43: 953–960
Article  Google Scholar 
55. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth
J, Bayer AS, Tang AW, Phung TO, Spellberg B 2005
Necrotizing fasciitis caused by community-associated
methicillin-resistant Staphylococcus aureus in Los Angeles. N
Engl J Med 352: 1445–1453
Article  CAS  Google Scholar 
56. Miller LG, Quan C, Shay A, Mostafaie K, Bharadwa K, Tan N,
Matayoshi K, Cronin J, Tan J, Tagudar G, Bayer AS 2007 A
prospective investigation of outcomes after hospital discharge
for endemic, community-acquired methicillin-resistant and -
susceptible Staphylococcus aureus skin infection. Clin Infect Dis
44: 483–492
Article  Google Scholar 
57. Bocchini CE, Hulten KG, Mason EO Jr, Gonzalez BE,
Hammerman WA, Kaplan SL 2006 Panton-Valentine leukocidin
genes are associated with enhanced inflammatory response
and local disease in acute hematogenous Staphylococcus
aureus osteomyelitis in children. Pediatrics 117: 433–440
Article  Google Scholar 
58. Miller LG, Diep BA 2008 Clinical practice: colonization,
fomites, and virulence: rethinking the pathogenesis of
community-associated methicillin-resistant Staphylococcus
aureus infection. Clin Infect Dis 46: 752–760


Article  CAS  Google Scholar 
59. Diep BA, Chambers HF, Graber CJ, Szumowski JD, Miller LG,
Han LL, Chen JH, Lin F, Lin J, Phan TH, Carleton HA,
McDougal LK, Tenover FC, Cohen DE, Mayer KH, Sensabaugh
GF, Perdreau-Remington F 2008 Emergence of multidrug-
resistant, community-associated, methicillin-resistant
Staphylococcus aureus clone USA300 in men who have sex
with men. Ann Intern Med 148: 249–257
Article  Google Scholar 
60. Boyle-Vavra S, Daum RS 2007 Community-acquired
methicillin-resistant Staphylococcus aureus: the role of Panton-
Valentine leukocidin. Lab Invest 87: 3–9
Article  CAS  Google Scholar 
61. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann
H, Edwards G, O'Brien FG, Tenover FC, McDougal LK, Monk
AB, Enright MC 2005 Re-emergence of early pandemic
Staphylococcus aureus as a community-acquired meticillin-
resistant clone. Lancet 365: 1256–1258
Article  Google Scholar 
62. Gillet Y, Etienne J, Lina G, Vandenesch F 2008 Association of
necrotizing pneumonia with panton-valentine leukocidin-
producing Staphylococcus aureus, regardless of methicillin
resistance. Clin Infect Dis 47: 985–986
Article  Google Scholar 
63. Yamasaki O, Kaneko J, Morizane S, Akiyama H, Arata J,
Narita S, Chiba J, Kamio Y, Iwatsuki K 2005 The association
between Staphylococcus aureus strains carrying panton-
valentine leukocidin genes and the development of deep-seated
follicular infection. Clin Infect Dis 40: 381–385
Article  Google Scholar 
64. Cribier B, Prevost G, Couppie P, Finck-Barbancon V,


Grosshans E, Piemont Y 1992 Staphylococcus aureus
leukocidin: a new virulence factor in cutaneous infections?
An epidemiological and experimental study. Dermatology 185:
175–180
Article  CAS  Google Scholar 
65. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M,
Benito Y, Barbu EM, Vazquez V, Hook M, Etienne J,
Vandenesch F, Bowden MG 2007 Staphylococcus aureus
Panton-Valentine leukocidin causes necrotizing pneumonia.
Science 315: 1130–1133
Article  CAS  Google Scholar 
66. Szmigielski S, Prevost G, Monteil H, Colin DA, Jeljaszewicz J
1999 Leukocidal toxins of staphylococci. Zentralbl Bakteriol
289: 185–201
Article  CAS  Google Scholar 
67. Genestier AL, Michallet MC, Prevost G, Bellot G, Chalabreysse
L, Peyrol S, Thivolet F, Etienne J, Lina G, Vallette FM,
Vandenesch F, Genestier L 2005 Staphylococcus aureus Panton-
Valentine leukocidin directly targets mitochondria and induces
Bax-independent apoptosis of human neutrophils. J Clin Invest
115: 3117–3127
Article  CAS  Google Scholar 
68. Konig B, Koller M, Prevost G, Piemont Y, Alouf JE, Schreiner
A, Konig W 1994 Activation of human effector cells by
different bacterial toxins (leukocidin, alveolysin, and
erythrogenic toxin A): generation of interleukin-8. Infect
Immun 62: 4831–4837
CAS  PubMed  PubMed Central  Google Scholar 
69. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M,
Schneewind O, DeLeo FR 2008 Panton-Valentine leukocidin is
not a virulence determinant in murine models of community-
associated methicillin-resistant Staphylococcus aureus disease.


J Infect Dis 198: 1166–1170
Article  Google Scholar 
70. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind
O 2007 Poring over pores: alpha-hemolysin and Panton-
Valentine leukocidin in Staphylococcus aureus pneumonia. Nat
Med 13: 1405–1406
Article  Google Scholar 
71. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR,
Welty D, Long RD, Dorward DW, Gardner DJ, Lina G,
Kreiswirth BN, DeLeo FR 2006 Is Panton-Valentine leukocidin
the major virulence determinant in community-associated
methicillin-resistant Staphylococcus aureus disease?. J Infect
Dis 194: 1761–1770
Article  CAS  Google Scholar 
72. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson
MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF,
Perdreau-Remington F 2006 Complete genome sequence of
USA300, an epidemic clone of community-acquired
meticillin-resistant Staphylococcus aureus. Lancet 367: 731–
739
Article  CAS  Google Scholar 
73. Montgomery CP, Boyle-Vavra S, Adem PV, Lee JC, Husain
AN, Clasen J, Daum RS 2008 Comparison of virulence in
community-associated methicillin-resistant Staphylococcus
aureus pulsotypes USA300 and USA400 in a rat model of
pneumonia. J Infect Dis 198: 561–570
Article  CAS  Google Scholar 
74. Shultz LD, Ishikawa F, Greiner DL 2007 Humanized mice in
translational biomedical research. Nat Rev Immunol 7: 118–
130
Article  CAS  Google Scholar 


75. Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian
JF, Fierer J, Nizet V 2005 Staphylococcus aureus golden
pigment impairs neutrophil killing and promotes virulence
through its antioxidant activity. J Exp Med 202: 209–215
Article  CAS  Google Scholar 
76. Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, Nizet V,
Wang AH, Oldfield E 2008 A cholesterol biosynthesis
inhibitor blocks Staphylococcus aureus virulence. Science 319:
1391–1394
Article  CAS  Google Scholar 
77. Bubeck Wardenburg J, Schneewind O 2008 Vaccine
protection against Staphylococcus aureus pneumonia. J Exp
Med 205: 287–294
Article  Google Scholar 
78. Schaffer AC, Lee JC 2008 Vaccination and passive
immunisation against Staphylococcus aureus. Int J Antimicrob
Agents 32: S71–S78
Article  CAS  Google Scholar 
79. Ellis MW, Griffith ME, Dooley DP, McLean JC, Jorgensen JH,
Patterson JE, Davis KA, Hawley JS, Regules JA, Rivard RG,
Gray PJ, Ceremuga JM, Dejoseph MA, Hospenthal DR 2007
Targeted intranasal mupirocin to prevent colonization and
infection by community-associated methicillin-resistant
Staphylococcus aureus strains in soldiers: a cluster randomized
controlled trial. Antimicrob Agents Chemother 51: 3591–3598
Article  CAS  Google Scholar 
80. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G,
McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover
FC, Kuehnert MJ 2001 Changes in the prevalence of nasal
colonization with Staphylococcus aureus in the United
States-2004. J Infect Dis 197: 1226–1234, 2008


Article  Google Scholar 
Download references
Acknowledgements
We thank Drs. Binh Diep, Delores Tseng, and Terence Doherty for
critical reading of this review.
Author information
Author notes
1. George Y Liu: G. Y. Liu is the recipient of a Burroughs-
Wellcome Career Award and a National Institutes of Health
grant AI074832.
Authors and Affiliations
1. Division of Pediatric Infectious Diseases and the
Immunobiology Research Institute, Cedars-Sinai Medical
Center, Los Angeles, 90048, California
George Y Liu
2. Department of Pediatrics, University of California, Los
Angeles, 90025, California
George Y Liu
Authors
1. George Y Liu
View author publications
Search author on:PubMed Google Scholar
Corresponding author


Correspondence to George Y Liu.
Rights and permissions
Reprints and permissions
About this article
Cite this article
Liu, G. Molecular Pathogenesis of Staphylococcus aureus Infection.
Pediatr Res 65, 71–77 (2009). https://doi.org/10.1203/
PDR.0b013e31819dc44d
Download citation
•  Received: 04 November 2008
•  Accepted: 13 January 2009
•  Issue date: May 2009
•  DOI: https://doi.org/10.1203/PDR.0b013e31819dc44d
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative


This article is cited by
•  Characterization and pathogenicity of multidrug-
resistant coagulase-negative Staphylococci
isolates in chickens
○  Hend K. Sorour
○  Azhar G. Shalaby
○  Reham A. Hosny
International Microbiology (2023)
•  Effect of spdC gene expression on virulence and
antibiotic resistance in clinical Staphylococcus
aureus isolates
○  Mayada E. Bakr
○  Mona T. Kashef
○  Mohammed A. Ramadan
International Microbiology (2022)
•  Quorum sensing inhibitory potential of vaccenic
acid against Chromobacterium violaceum and
methicillin-resistant Staphylococcus aureus
○  Vijayakumar Karuppiah
○  Muhilvannan Seralathan
World Journal of Microbiology and Biotechnology (2022)
•  Whole genome sequencing revealed new
molecular characteristics in multidrug resistant
staphylococci recovered from high frequency
touched surfaces in London
○  Rory Cave
○  Raju Misra


○  Hermine V. Mkrtchyan
Scientific Reports (2019)
•  Staphylococcus aureus induces DNA damage in
host cell
○  Martine Deplanche
○  Nassim Mouhali
○  Nadia Berkova
Scientific Reports (2019)
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Podcasts
•  Videos
•  Current issue
•  Collections
•  Follow us on Twitter
•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Journal Information


•  About the Editors
•  Contact
•  About the Partners
•  For Advertisers
•  Subscribe
•  Announcements
Publish with us
•  For Authors & Referees
•  Language editing services
•  Open access funding
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Pediatric Research (Pediatr Res)
ISSN 1530-0447 (online)
ISSN 0031-3998 (print)
nature.com sitemap


About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services


•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


[image]


